CARMAT Announces a Software Enhancement Which Significantly Improves the Safety Profile of Its Aeson Artificial Heart finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
CARMAT Announces the Opening of Its New Production Facility in Bois-d Arcy, France finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
The facility and its equipment meet the highest standards for the production of medical devicesIts opening will enable the Company to reach a production capacity of 500 hearts per year as early as 2024, in line with its objectivesPARIS (BUSINESS WIRE) $carmat #alcar Regulatory News:CARMAT (FR0010907956, ALCAR), d.
BiVACOR, Inc., a pioneer in the development of total artificial hearts, has achieved a significant milestone with the USÂ Food and Drug Administration (FDA).
HUNTINGTON BEACH, Calif. & GOLD COAST, Australia & HOUSTON (BUSINESS WIRE) BiVACOR, Inc., a clinical-stage medical device company developing a total artificial heart (TAH), today announced the